Description

Phosphorylation controls life. It switches proteins on and off. It tunes signalling, binding, and fate. But it is also kind of messy. Natural phosphotyrosine is unstable. Cells add it and remove it constantly. Purified proteins lose it. Heterogeneity creeps in. Mechanism gets blurred.

This work shows a clean way forward: genetically encoding a new-to-nature phosphotyrosine mimetic directly into proteins. The amino acid is called pentafluorophosphatophenylalanine (PF5CF2Phe). When this ncAA was placed into a small protein scaffold, the result was striking: a protein that strongly inhibits PTP1B and SHP2, two clinically important tyrosine phosphatases – something that was not achieved by the native protein scaffold. This is the key lesson from this paper: the single ncAA flipped the function. ncAAs are not decorations - they are functional switches.

Citation: Ambros et al., 2026

Phosphorylation is the most common protein regulatory mechanism, but natural phosphotyrosine is unstable, rapidly removed by cellular phosphatases, and lost during purification. This makes it difficult to study or exploit therapeutically. A non-hydrolysable phosphotyrosine mimetic, genetically encoded, addresses this.

Pentafluorophosphatophenylalanine (PF5CF2Phe), incorporated site-specifically into a small protein scaffold, produced a stable phosphatase inhibitor that could not be generated with any natural amino acid. The modified protein strongly inhibited PTP1B and SHP2, two clinically relevant tyrosine phosphatases. The unmodified scaffold showed no inhibition; the single ncAA substitution switched the protein's function entirely (Ambros et al., 2026).

This illustrates that ncAAs can serve as functional switches, not merely optimisation tools. One substitution converted a non-functional protein into a potent inhibitor. For drug development, stable phosphomimetics enable therapeutic targeting of phosphotyrosine-dependent signalling pathways without the instability of natural phosphorylation.

Source publication